Page last updated: 2024-11-04

terbutaline and Familial Periodic Paralysis

terbutaline has been researched along with Familial Periodic Paralysis in 2 studies

Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.

Research Excerpts

ExcerptRelevanceReference
"Treatment with terbutaline, a Na/K-ATPase-stimulating drug, resulted in attack-free periods of approximately 9 months, after which the attacks reoccurred."1.30Multiple anomalies, hypokalaemic paralysis and partial symptomatic relief by terbutaline. ( Andersen, PE; Djurhuus, MS; Jensen, BM; Klitgaard, NA; Schrøder, HD, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Surrow, J1
Sjølin, SU1
Djurhuus, MS1
Klitgaard, NA1
Jensen, BM1
Andersen, PE1
Schrøder, HD1

Other Studies

2 other studies available for terbutaline and Familial Periodic Paralysis

ArticleYear
[Terbutaline treatment of familial hyperkalemic periodic paralysis].
    Ugeskrift for laeger, 1984, Sep-03, Volume: 146, Issue:36

    Topics: Adolescent; Adult; Aged; Child; Female; Humans; Hyperkalemia; Male; Paralyses, Familial Periodic; Te

1984
Multiple anomalies, hypokalaemic paralysis and partial symptomatic relief by terbutaline.
    Acta paediatrica (Oslo, Norway : 1992), 1998, Volume: 87, Issue:4

    Topics: Abnormalities, Multiple; Arrhythmias, Cardiac; Child; Fatal Outcome; Humans; Hypokalemia; Male; Mand

1998